Oxytocin: A Multi-Functional Biomolecule with Potential Actions in Dysfunctional Conditions; From Animal Studies and Beyond

[Initiation and endocrine control of parturition in domestic mammals - Part 1]

Endocrine regulation of parturition is based on an intense exchange of signals between the fetus, placenta and mother. Apart from sheep, our knowledge of the endocrine control of parturition is still very incomplete. However, current observations suggest significant differences between the species. For the maintenance of pregnancy, progesterone (P4) is the crucial superordinate regulatory factor, although in some species, such as the horse, functions of P4 are at least partially fulfilled by other progestogens. In general, prepartum P4 withdrawal is considered a prerequisite for the onset of physiological birth. In species with exclusive (dog) or predominant (e. g., cattle, goat, pig) luteal P4 at the end of gestation, luteolysis is the crucial event. In sheep, where P4 is of placental origin prior to parturition, the prepartum P4 decline is due to a switch in placental steroid metabolism. The mechanism of prepartum progestogen withdrawal in the mare is still largely unclear. In sheep, initiation of parturition proceeds from maturation of the fetal hypothalamic-pituitary-adrenal (HPA) axis, which leads to a steep prepartum rise in fetal cortisol concentrations stimulating the collapse of placental P4 production. In cattle, fetal cortisol probably triggers luteolysis via stimulation of placental prostaglandin secretion. In several other domestic mammalian species, there is also evidence that the initiation of parturition proceeds from maturation of the fetal HPA axis. However, the functional relationships between fetal cortisol and prepartum P4 withdrawal are largely unknown in nonruminant species.

The Role of Oxytocin in Domestic Animal’s Maternal Care: Parturition, Bonding, and Lactation

Oxytocin (OXT) is one of the essential hormones in the birth process; however, estradiol, prolactin, cortisol, relaxin, connexin, and prostaglandin are also present. In addition to parturition, the functions in which OXT is also involved in mammals include the induction of maternal behavior, including imprinting and maternal care, social cognition, and affiliative behavior, which can affect allo-parental care. The present article aimed to analyze the role of OXT and the neurophysiologic regulation of this hormone during parturition, how it can promote or impair maternal behavior and bonding, and its importance in lactation in domestic animals.

The Long Way of Oxytocin from the Uterus to the Heart in 70 Years from Its Discovery

The research program on oxytocin started in 1895, when Oliver and Schafer reported that a substance extracted from the pituitary gland elevates blood pressure when injected intravenously into dogs. Dale later reported that a neurohypophysial substance triggers uterine contraction, lactation, and antidiuresis. Purification of this pituitary gland extracts revealed that the vasopressor and antidiuretic activity could be attributed to vasopressin, while uterotonic and lactation activity could be attributed to oxytocin. In 1950, the amino-acid sequences of vasopressin and oxytocin were determined and chemically synthesized. Vasopressin (CYFQNCPRG-NH₂) and oxytocin (CYIQNCPLG-NH₂) differ by two amino acids and have a disulfide bridge between the cysteine residues at position one and six conserved in all vasopressin/oxytocin-type peptides. This characterization of oxytocin led to the Nobel Prize awarded in 1955 to Vincent du Vigneaud. Nevertheless, it was only 50 years later when the evidence that mice depleted of oxytocin or its receptor develop late-onset obesity and metabolic syndrome established that oxytocin regulates energy and metabolism. Oxytocin is anorexigenic and regulates the lean/fat mass composition in skeletal muscle. Oxytocin's effect on muscle is mediated by thermogenesis via a pathway initiated in the myocardium. Oxytocin involvement in thermogenesis and muscle contraction is linked to Prader-Willi syndrome in humans, opening exciting therapeutic avenues.